Wikidata entity: Q410352
C₉H₁₇NO₂ (P274)
Quantities
| P4250 | defined daily dose | 1.8 |
| P2067 | mass | 171.126 |
| P3780 | active ingredient in | ... | Q47521669 (Gralise) | Gralise |
| P3780 | active ingredient in | ... | Q47521685 (Horizant) | Horizant |
| P3780 | active ingredient in | ... | Q47521891 (Neurontin) | Neurontin |
| P233 | canonical SMILES | String | C1CCC(CC1)(CC(=O)O)CN | ??? |
| P373 | Commons category | String | Gabapentin | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P366 | has use | ... | Q3184856 (substance abuse) | substance abuse |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Gabapentin%20molecule%20spacefill.png | ??? |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Gabapentin3Dan.gif | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P176 | manufacturer | ... | Q206921 (Pfizer) | Pfizer |
| P2175 | medical condition treated | ... | Q8277 (multiple sclerosis) | multiple sclerosis |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q133823 (migraine) | migraine |
| P2175 | medical condition treated | ... | Q154430 (anxiety) | anxiety |
| P2175 | medical condition treated | ... | Q131755 (bipolar disorder) | bipolar disorder |
| P2175 | medical condition treated | ... | Q170990 (arthritis) | arthritis |
| P2175 | medical condition treated | ... | Q175180 (radiculopathy) | radiculopathy |
| P2175 | medical condition treated | ... | Q182155 (herpes zoster) | herpes zoster |
| P2175 | medical condition treated | ... | Q540571 (fibromyalgia) | fibromyalgia |
| P2175 | medical condition treated | ... | Q281928 (social anxiety disorder) | social anxiety disorder |
| P2175 | medical condition treated | ... | Q693519 (essential tremor) | essential tremor |
| P2175 | medical condition treated | ... | Q916280 (restless legs syndrome) | restless legs syndrome |
| P2175 | medical condition treated | ... | Q3184856 (substance abuse) | substance abuse |
| P2175 | medical condition treated | ... | Q945238 (peripheral neuropathy) | peripheral neuropathy |
| P2175 | medical condition treated | ... | Q1066311 (complex regional pain syndrome) | complex regional pain syndrome |
| P2175 | medical condition treated | ... | Q1129105 (diabetic nephropathy) | diabetic nephropathy |
| P2175 | medical condition treated | ... | Q1132120 (trigeminal neuralgia) | trigeminal neuralgia |
| P2175 | medical condition treated | ... | Q1869874 (insomnia) | insomnia |
| P2175 | medical condition treated | ... | Q3339235 (neurological disorder) | neurological disorder |
| P2175 | medical condition treated | ... | Q7140388 (focal epilepsy) | focal epilepsy |
| P2175 | medical condition treated | ... | Q54972453 (sleep-wake disorder) | sleep-wake disorder |
| P2175 | medical condition treated | ... | Q55781316 (osteoarthritis susceptibility 1) | osteoarthritis susceptibility 1 |
| P3489 | pregnancy category | ... | Q3679232 (Australian pregnancy category B1) | Australian pregnancy category B1 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q81225 (morphine) | morphine |
| P279 | subclass of | ... | Q74034622 (Gamma-amino acids) | Gamma-amino acids |
| P2868 | subject has role | ... | Q62903 (anxiolytic) | anxiolytic |
| P2868 | subject has role | ... | Q173235 (analgesic) | analgesic |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q421700 (calcium channel blocker) | calcium channel blocker |
| P2868 | subject has role | ... | Q3579672 (antiparkinson) | antiparkinson |
| P2868 | subject has role | ... | Q5419644 (excitatory amino acid antagonist) | excitatory amino acid antagonist |
| P2868 | subject has role | ... | Q11497468 (antimanic agents) | antimanic agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | gabapentin | ??? |
Why not click here or view trends?
log id: 1787195